Novavax, Canada and COVID-19
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
Novavax (NASDAQ:NVAX) shares fell ~3% in the premarket on Thursday after the company issued a clarification on an analyst ...
On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated ...
The Canadian Press on MSN3d
For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is 'unfair,' advocates sayThe federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...
Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...
"A lot of people I speak with are actually surprised to hear that we are seeing severe COVID still. It is still a thing." Health Canada also approved the protein-based Novavax vaccine (Nuvaxovid ...
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back. Recently, Zacks.com users have been paying close ...
Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback